Albuterol
-
Subject Areas on Research
- Adjunctive albuterol enhances the response to enzyme replacement therapy in late-onset Pompe disease.
- Airway smooth muscle dysfunction in Pompe (Gaa-/- ) mice.
- Airway tissue mast cells in persistent asthma: predictor of treatment failure when patients discontinue inhaled corticosteroids.
- An Asthma Protocol Improved Adherence to Evidence-Based Guidelines for Pediatric Subjects With Status Asthmaticus in the Emergency Department.
- Anticholinergic vs Long-Acting β-Agonist in Combination With Inhaled Corticosteroids in Black Adults With Asthma: The BELT Randomized Clinical Trial.
- Beneficial effects of albuterol therapy driven by heliox versus by oxygen in severe asthma exacerbation.
- Beta2-receptor polymorphisms in patients receiving salmeterol with or without fluticasone propionate.
- Bronchiolitis.
- Childhood asthma clusters and response to therapy in clinical trials.
- Combination therapy with a long-acting beta-agonist and a leukotriene antagonist in moderate asthma.
- Contamination of nebulizer equipment with cockroach allergen: there's a bug in the system!
- Dispensing home nebulizers for acute wheezing from the hospital is cost-effective.
- Early management of acute severe asthma.
- Editorial: Selectivity in beta-adrenergic responses: clinical implications.
- Effect of beta2-adrenergic receptor polymorphism on response to longacting beta2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trial.
- Effect of polymorphism of the beta(2)-adrenergic receptor on response to regular use of albuterol in asthma.
- Enterovirus D68 Infection in an Adult.
- GSNO reductase and beta2-adrenergic receptor gene-gene interaction: bronchodilator responsiveness to albuterol.
- Impact of race on asthma treatment failures in the asthma clinical research network.
- Individualized therapy for persistent asthma in young children.
- Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol: a randomized controlled trial.
- Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial.
- Meeting the obligation to balance bioethics and clinical trial design in asthma.
- Nocturnal awakening caused by asthma in children with mild-to-moderate asthma in the childhood asthma management program.
- Non-parametric estimation for the difference or ratio of median failure times for paired observations.
- P2X7-regulated protection from exacerbations and loss of control is independent of asthma maintenance therapy.
- Predictors of response to tiotropium versus salmeterol in asthmatic adults.
- Quintupling Inhaled Glucocorticoids to Prevent Childhood Asthma Exacerbations.
- Randomized, placebo-controlled clinical trial of an aerosolized β₂-agonist for treatment of acute lung injury.
- Safety of a peanut oral immunotherapy protocol in children with peanut allergy.
- Salmeterol powder compared with albuterol aerosol as maintenance therapy for asthma in adolescent and adult patients.
- Signal transduction. Bringing channels closer to the action!
- Sputum eosinophil counts predict asthma control after discontinuation of inhaled corticosteroids.
- The Childhood Asthma Management Program (CAMP): design, rationale, and methods. Childhood Asthma Management Program Research Group.
- The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma.
- Tiotropium bromide step-up therapy for adults with uncontrolled asthma.
- Treatment of hyperkalaemia using intravenous and nebulised salbutamol.
- Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial.
- Using Hyperpolarized 129Xe MRI to Quantify the Pulmonary Ventilation Distribution.
- beta-Adrenergic receptor polymorphisms and response to salmeterol.
- β2 Agonists enhance the efficacy of simultaneous enzyme replacement therapy in murine Pompe disease.